PharmaCyte Biotech, Inc.
General ticker "PMCB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $8.7M (TTM average)
PharmaCyte Biotech, Inc. does not follow the US Stock Market performance with the rate: -19.9%.
Estimated limits based on current volatility of 16.1%: low 0.81$, high 1.12$
Factors to consider:
- Earnings expected soon, date: 2025-12-12 bmo
- Total employees count: 2 (0.0%) as of 2024
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: FDA clinical hold, Limited operating history, Inability to raise capital, Regulatory and compliance, Inexperience in clinical trials